{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T17:39:23Z","timestamp":1794418763230,"version":"4.9.1"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015800","name":"Jilin Province Development and Reform Commission","doi-asserted-by":"publisher","award":["2023C039-3"],"award-info":[{"award-number":["2023C039-3"]}],"id":[{"id":"10.13039\/100015800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472620"],"award-info":[{"award-number":["82472620"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009991","name":"Department of Finance of Jilin Province","doi-asserted-by":"publisher","award":["2023SCZ69"],"award-info":[{"award-number":["2023SCZ69"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013061","name":"Jilin Provincial Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20230203089SF"],"award-info":[{"award-number":["20230203089SF"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.metabol.2026.156547","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T07:48:50Z","timestamp":1770709730000},"page":"156547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging: Mechanisms and therapeutic potential"],"prefix":"10.1016","volume":"178","author":[{"given":"Mo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanguo","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2026.156547_bb0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.34297\/AJBSR.2022.16.002205","article-title":"Halalopathy: Role of entropy in the aging process","volume":"16","author":"Alzeer","year":"2022","journal-title":"AJBSR"},{"key":"10.1016\/j.metabol.2026.156547_bb0010","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","article-title":"The senescence-associated secretory phenotype and its physiological and pathological implications","volume":"25","author":"Wang","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.metabol.2026.156547_bb0015","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.cell.2025.03.011","article-title":"From geroscience to precision geromedicine: Understanding and managing aging","volume":"188","author":"Kroemer","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2026.156547_bb0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041197","article-title":"Aging and inflammation","volume":"14","author":"Singh","year":"2024","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0025","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2337\/dci24-0003","article-title":"Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity","volume":"47","author":"Drucker","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156547_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.metabol.2026.156547_bb0035","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: Cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.metabol.2026.156547_bb0040","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jhep.2023.07.033","article-title":"Incretins (GLP-1 receptor agonists and dual\/triple agonists) and the liver","volume":"79","author":"Newsome","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.metabol.2026.156547_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175439","article-title":"Alternative role of glucagon-like peptide-1 receptor agonists in neurodegenerative diseases","volume":"938","author":"Chen","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0050","article-title":"Potential use of GLP-1 and GIP\/GLP-1 receptor agonists for respiratory disorders: where are we at?","volume":"60","author":"Jani\u0107","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.metabol.2026.156547_bb0055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41574-024-01000-z","article-title":"Gut hormones and bone homeostasis: Potential therapeutic implications","volume":"20","author":"Bouvard","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.metabol.2026.156547_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12964-024-01663-1","article-title":"Molecular mechanisms of aging and anti-aging strategies","volume":"22","author":"Li","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.metabol.2026.156547_bb0065","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41586-021-03307-7","article-title":"The central role of DNA damage in the ageing process","volume":"592","author":"Schumacher","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156547_bb0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.freeradbiomed.2025.03.012","article-title":"The nuclear-mitochondrial crosstalk in aging: From mechanisms to therapeutics","volume":"232","author":"Feng","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: From mechanisms to therapeutic opportunities","volume":"22","author":"Di Micco","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.metabol.2026.156547_bb0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41556-022-00842-x","article-title":"Telomere dysfunction in ageing and age-related diseases","volume":"24","author":"Rossiello","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.metabol.2026.156547_bb0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/biom15030404","article-title":"Pathological and inflammatory consequences of aging","volume":"15","author":"Garc\u00eda-Dom\u00ednguez","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.metabol.2026.156547_bb0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-012419-032847","article-title":"DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation","volume":"15","author":"Zindel","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.metabol.2026.156547_bb0095","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.metabol.2026.156547_bb0100","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/s41591-023-02296-6","article-title":"Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality","volume":"29","author":"Tian","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0105","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.metabol.2026.156547_bb0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1074-7613(02)00423-5","article-title":"The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways","volume":"17","author":"Dejardin","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2026.156547_bb0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imr.13279","article-title":"PANoptosis: Mechanisms, biology, and role in disease","volume":"321","author":"Sun","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.metabol.2026.156547_bb0125","article-title":"Exosomes derived from FN14-overexpressing BMSCs activate the NF-\u03baB signaling pathway to induce PANoptosis in osteosarcoma","volume":"30","author":"L","year":"2025","journal-title":"Apoptosis Int. J. Progr. Cell Death"},{"key":"10.1016\/j.metabol.2026.156547_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.fsi.2025.110374","article-title":"Nano-selenium alleviates tetrabromobisphenol A induced PANoptosis in carp gill tissue by inhibiting TLR4\/MyD88\/NF-\u03baB pathway","volume":"163","author":"Lou","year":"2025","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.metabol.2026.156547_bb0135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.metabol.2026.156547_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117152","article-title":"Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes","volume":"241","author":"Yaribeygi","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.metabol.2026.156547_bb0145","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s43587-025-00869-3","article-title":"Activation of AMPK by GLP-1R agonists mitigates alzheimer-related phenotypes in transgenic mice","volume":"5","author":"Zhang","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.metabol.2026.156547_bb0150","article-title":"GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion","volume":"67","author":"Nr G","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2026.156547_bb0155","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.17219\/acem\/151695","article-title":"GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: Current research and future horizons","volume":"31","author":"Papaetis","year":"2022","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.metabol.2026.156547_bb0165","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s10020-022-00574-6","article-title":"Exenatide regulates Th17\/treg balance via PI3K\/akt\/FoxO1 pathway in db\/db mice","volume":"28","author":"Xu","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0170","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1464-5491.2008.02484.x","article-title":"Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with type 2 diabetes","volume":"25","author":"Courreges","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diabres.2015.12.003","article-title":"Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide","volume":"113","author":"Savvidou","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.metabol.2026.156547_bb0180","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/dom.12680","article-title":"Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: A prospective randomized clinical trial using magnetic resonance imaging and spectroscopy","volume":"18","author":"Dutour","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.metabol.2026.156547_bb0185","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.metabol.2016.03.009","article-title":"Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study","volume":"65","author":"Farr","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156547_bb0190","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2337\/dc15-2782","article-title":"Glucose variability in a 26-week randomized comparison of mealtime treatment with rapid-acting insulin versus GLP-1 agonist in participants with type 2 diabetes at high cardiovascular risk","volume":"39","author":"FLAT-SUGAR Trial Investigators","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156547_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/srep16968","article-title":"Glucose variability and \u03b2- cell response by GLP-1 analogue added-on CSII for patients with poorly controlled type 2 diabetes","volume":"5","author":"Lin","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.metabol.2026.156547_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-015-0279-z","article-title":"Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study","volume":"14","author":"Sim\u00f3","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.metabol.2026.156547_bb0205","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jdi.12269","article-title":"Vildagliptin vs liraglutide as a second-line therapy switched from sitagliptin-based regimens in patients with type 2 diabetes: a randomized, parallel-group study","volume":"6","author":"Takeshita","year":"2015","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.metabol.2026.156547_bb0210","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00592-014-0638-3","article-title":"Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes","volume":"51","author":"Bi","year":"2014","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.metabol.2026.156547_bb0215","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.diabres.2014.09.046","article-title":"Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers","volume":"106","author":"Gurkan","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.metabol.2026.156547_bb0220","first-page":"211","article-title":"Greater efficacy and improved endothelial dysfunction in untreated type 2 diabetes with liraglutide versus sitagliptin","volume":"41","author":"Suzuki","year":"2014","journal-title":"Dokkyo J. Med. Sci."},{"key":"10.1016\/j.metabol.2026.156547_bb0225","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1590\/S0004-27302013000900005","article-title":"Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease","volume":"57","author":"Fan","year":"2013","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.metabol.2026.156547_bb0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.diabres.2013.04.005","article-title":"Effect of laparoscopic roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: A randomized controlled trial","volume":"101","author":"Liang","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.metabol.2026.156547_bb0235","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1464-5491.2012.03699.x","article-title":"Exenatide plus metformin compared with metformin alone on \u03b2-cell function in patients with type 2 diabetes","volume":"29","author":"Derosa","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0240","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1464-5491.2012.03589.x","article-title":"Addition of liraglutide in patients with type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function","volume":"29","author":"Forst","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0245","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/dia.2010.0048","article-title":"Effect of exenatide on inflammatory and oxidative stress markers in patients with type 2 diabetes mellitus","volume":"13","author":"Wu","year":"2011","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.metabol.2026.156547_bb0250","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.2337\/dc09-2361","article-title":"Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition","volume":"33","author":"Bunck","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156547_bb0255","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/dia.2009.0141","article-title":"Exenatide versus glibenclamide in patients with diabetes","volume":"12","author":"Derosa","year":"2010","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.metabol.2026.156547_bb0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3892\/etm.2023.11948","article-title":"Effect of liraglutide on atherosclerosis in patients with impaired glucose tolerance: A double-blind, randomized controlled clinical trial","volume":"25","author":"Sun","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1088187","article-title":"Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease","volume":"14","author":"Ying","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.metabol.2026.156547_bb0270","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12933-022-01634-1","article-title":"Effects of dulaglutide on endothelial progenitor cells and arterial elasticity in patients with type 2 diabetes mellitus","volume":"21","author":"Xie","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.metabol.2026.156547_bb0275","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/dom.14343","article-title":"Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial","volume":"23","author":"Ahmad","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.metabol.2026.156547_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99527-y","article-title":"Effects of exenatide on urinary albumin in overweight\/obese patients with T2DM: a randomized clinical trial","volume":"11","author":"Kang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.metabol.2026.156547_bb0285","first-page":"1325","article-title":"Effects and characteristics of liraglutide and its correlation with intestinal microflora in patients with type 2 diabetes","volume":"16","author":"Li","year":"2021","journal-title":"J. Pathogen. Biol."},{"key":"10.1016\/j.metabol.2026.156547_bb0290","first-page":"400","article-title":"Clinical trial of liraglutide in the treatment of patients with type 2 diabetes mellitus and non-alcoholic fatty liver","volume":"36","author":"Zhengrong","year":"2020","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0295","first-page":"1453","article-title":"Clinical trial of liraglutide injection combined with metformin tablets in the treatment of patients with type 2 diabetes mellitus and obesity","volume":"36","author":"Na","year":"2020","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0300","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20198652","article-title":"Use of flash glucose-sensing technology in patients with type 2 diabetes treated with liraglutide combined with CSII: A pilot study","volume":"53","author":"Yao","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.metabol.2026.156547_bb0305","first-page":"2765","article-title":"Clinical trial of liraglutide combined with insulin injection in the treatment of patients with type 2 diabetes mellitus","volume":"36","author":"Zhengli","year":"2020","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0310","first-page":"1219","article-title":"Comparison between the effects of sitagliptin and liraglutide on blood glucose and cognitive function of patients with both type 2 diabetes mellitus and post-stroke mild cognitive impairment","volume":"13","author":"Wang","year":"2020","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0315","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2019.07.007","article-title":"Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial","volume":"288","author":"Anholm","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2026.156547_bb0320","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/osp4.324","article-title":"Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: Evaluations from a randomized trial (MDI-liraglutide study 5)","volume":"5","author":"Ahmadi","year":"2019","journal-title":"Obes. Sci. Pract."},{"key":"10.1016\/j.metabol.2026.156547_bb0325","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6423987","article-title":"A randomized study to compare the effects of once-weekly dulaglutide injection and once-daily glimepiride on glucose fluctuation of type 2 diabetes mellitus patients: a 26-week follow-up","volume":"2019","author":"Li","year":"2019","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.metabol.2026.156547_bb0330","article-title":"A prospective randomized control study on effect of liraglutide on cardiovascular outcomes in type II diabetes mellitus","volume":"12","author":"Pavithra","year":"2019","journal-title":"Drug Invent. Today"},{"key":"10.1016\/j.metabol.2026.156547_bb0335","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.diabet.2018.08.010","article-title":"Effect of liraglutide on physical performance in type 2 diabetes: Results of a randomized, double-blind, controlled trial (LIPER2)","volume":"45","author":"W\u00e4gner","year":"2019","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.metabol.2026.156547_bb0340","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2682657","article-title":"The effects of once-weekly dulaglutide and insulin glargine on glucose fluctuation in poorly oral-antidiabetic controlled patients with type 2 diabetes mellitus","volume":"2019","author":"Wang","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.metabol.2026.156547_bb0345","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/hep.30320","article-title":"Liraglutide, sitagliptin, and insulin glargine added to metformin: The effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease","volume":"69","author":"Yan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156547_bb0350","article-title":"Clinical trial of liraglutide injection in the treatment of patients with overweight and obese type 2 diabetes mellitus complicated with microalbuminuria","volume":"34","author":"Xiaohong","year":"2019","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0355","first-page":"780","article-title":"Clinical trial of liraglutide injection in the treatment of patients with diabetes mellitus","volume":"34","author":"Fei","year":"2018","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0360","first-page":"1141","article-title":"Assessment of complex treatment influence on systemic inflammation in overweight type 2 diabetes patients","volume":"71","author":"Said","year":"2018","journal-title":"Wiad. Lek."},{"key":"10.1016\/j.metabol.2026.156547_bb0365","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12944-017-0609-0","article-title":"Liraglutide and metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease","volume":"16","author":"Liu","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.metabol.2026.156547_bb0370","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181304","article-title":"Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease","volume":"38","author":"Tian","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.metabol.2026.156547_bb0375","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1507\/endocrj.EJ16-0449","article-title":"Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: A randomized control trial","volume":"64","author":"Bouchi","year":"2017","journal-title":"Endocr. J."},{"key":"10.1016\/j.metabol.2026.156547_bb0380","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/CS20160803","article-title":"GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction","volume":"131","author":"Pastel","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.metabol.2026.156547_bb0385","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3892\/etm.2017.4863","article-title":"A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus","volume":"14","author":"Quan","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0390","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.orcp.2017.01.003","article-title":"Comparison of exenatide and acarbose on intra-abdominal fat content in patients with obesity and type-2 diabetes: A randomized controlled trial","volume":"11","author":"Shi","year":"2017","journal-title":"Obes. Res. Clin. Pract."},{"key":"10.1016\/j.metabol.2026.156547_bb0395","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/dom.12884","article-title":"Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial","volume":"19","author":"von Scholten","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.metabol.2026.156547_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111529","article-title":"Glucagon-like peptide-1 analogs mitigate neuroinflammation in alzheimer\u2019s disease by suppressing NLRP2 activation in astrocytes","volume":"542","author":"Zhang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.metabol.2026.156547_bb0405","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-021-01180-z","article-title":"Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer\u2019s disease","volume":"9","author":"Park","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.metabol.2026.156547_bb0410","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41586-025-08589-9","article-title":"Glycocalyx dysregulation impairs blood-brain barrier in ageing and disease","volume":"639","author":"Shi","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156547_bb0415","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pneurobio.2015.07.003","article-title":"Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies","volume":"155","author":"Bourdenx","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.metabol.2026.156547_bb0420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bpa.12545","article-title":"Autophagy in neurodegenerative diseases: Pathogenesis and therapy","volume":"28","author":"Guo","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.metabol.2026.156547_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.11.017","article-title":"NRF2 and NF-\u049bB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches","volume":"21","author":"Sivandzade","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.metabol.2026.156547_bb0430","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.adz4995","article-title":"Translational traffic jam in aging brains","volume":"389","author":"Dionne","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.metabol.2026.156547_bb0435","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","article-title":"Neuroinflammation pathways: A general review","volume":"127","author":"Shabab","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.metabol.2026.156547_bb0440","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.2147\/DDDT.S367229","article-title":"Protective effects of pioglitazone on cognitive impairment and the underlying mechanisms: A review of literature","volume":"16","author":"Alhowail","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.metabol.2026.156547_bb0445","doi-asserted-by":"crossref","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","article-title":"Normal aging induces A1-like astrocyte reactivity","volume":"115","author":"Clarke","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.metabol.2026.156547_bb0450","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/bph.15683","article-title":"The role of glia in the physiology and pharmacology of glucagon-like peptide-1: Implications for obesity, diabetes, neurodegeneration and glaucoma","volume":"179","author":"Cui","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0455","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/jnc.15521","article-title":"The metabolite GLP-1 (9-36) is neuroprotective and anti-inflammatory in cellular models of neurodegeneration","volume":"159","author":"Li","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.metabol.2026.156547_bb0460","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/receptors4010002","article-title":"Exploring the role of GLP-1 receptor agonists in alzheimer\u2019s disease: A review of preclinical and clinical evidence","volume":"4","author":"Teixeira","year":"2025","journal-title":"Receptors"},{"key":"10.1016\/j.metabol.2026.156547_bb0465","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13568-020-01014-6","article-title":"Therapeutic effect of GLP-1 engineered strain on mice model of alzheimer\u2019s disease and parkinson\u2019s disease","volume":"10","author":"Fang","year":"2020","journal-title":"AMB Express"},{"key":"10.1016\/j.metabol.2026.156547_bb0470","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaneurol.2025.0353","article-title":"GLP-1RA and SGLT2i medications for type 2 diabetes and alzheimer disease and related dementias","volume":"82","author":"Tang","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.metabol.2026.156547_bb0475","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/eurheartj\/ehaf216","article-title":"Obesity accelerates cardiovascular ageing","volume":"46","author":"Ruperez","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.metabol.2026.156547_bb0480","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.125.325531","article-title":"Cardiovascular Aging and Exercise: Implications for Heart Failure Prevention and Management","volume":"137","author":"Subramanian","year":"2025","journal-title":"Circ. Res."},{"key":"10.1016\/j.metabol.2026.156547_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102727","article-title":"Prevention of cardiovascular disease for healthy aging and longevity: A new scoring system and related \u201cmechanisms-hallmarks-biomarkers.\u201d","volume":"107","author":"Hu","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.metabol.2026.156547_bb0490","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.metabol.2026.156547_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110338","article-title":"Oxidized low-density lipoprotein regulates macrophage polarization in atherosclerosis","volume":"120","author":"He","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176338","article-title":"Hegemony of inflammation in atherosclerosis and coronary artery disease","volume":"966","author":"Attiq","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115200","article-title":"The Chinese medicine xin-tong-tai granule protects atherosclerosis by regulating oxidative stress through NOX\/ROS\/NF-\u03baB signal pathway","volume":"165","author":"Wei","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.metabol.2026.156547_bb0510","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jare.2021.06.023","article-title":"Activation of Nrf2\/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress","volume":"34","author":"Zhang","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.metabol.2026.156547_bb0515","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.metabol.2026.156547_bb0520","article-title":"A Cardiac-Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy-Induced Cardiac Ferroptosis and PANoptosis","volume":"12","author":"Xing","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.metabol.2026.156547_bb0525","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.metabol.2026.156547_bb0530","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2026.156547_bb0535","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12933-022-01604-7","article-title":"Tirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction","volume":"21","author":"Nauck","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.metabol.2026.156547_bb0540","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.metabol.2026.156547_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121045","article-title":"Liraglutide attenuates intestinal ischemia\/reperfusion injury via NF-\u03baB and PI3K\/akt pathways in mice","volume":"309","author":"Zou","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.metabol.2026.156547_bb0550","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10741-024-10450-6","article-title":"GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction","volume":"30","author":"Bonfioli","year":"2025","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.metabol.2026.156547_bb0555","article-title":"Grape pomace as a cardiometabolic health-promoting ingredient: activity in the intestinal environment","volume":"12","author":"Taladrid","year":"2023","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.metabol.2026.156547_bb0560","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fphys.2020.00036","article-title":"Molecular dynamics of lipopolysaccharide-induced lung injury in rodents","volume":"11","author":"Domscheit","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.metabol.2026.156547_bb0565","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s10020-022-00500-w","article-title":"ISM1 suppresses LPS-induced acute lung injury and post-injury lung fibrosis in mice","volume":"28","author":"Nguyen","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0570","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12967-022-03337-3","article-title":"Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4\/NF-kB signaling pathway","volume":"20","author":"Wu","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0575","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-020-2882-8","article-title":"Inhibition of LT\u03b2R signalling activates WNT-induced regeneration in lung","volume":"588","author":"Conlon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156547_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108197","article-title":"Glucagon-like peptide 1 (GLP-1) receptor agonists and asthma and COPD exacerbations in adults with diabetes: A systematic review","volume":"245","author":"Cooper","year":"2025","journal-title":"Respir. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0585","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvz034","article-title":"Glucagon-like peptide 1 and atrial natriuretic peptide in a female mouse model of obstructive pulmonary disease","volume":"4","author":"Balk-M\u00f8ller","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.metabol.2026.156547_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051105","article-title":"Endothelial progenitor cells as pathogenetic and diagnostic factors, and potential targets for GLP-1 in combination with metabolic syndrome and chronic obstructive pulmonary disease","volume":"20","author":"Skurikhin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.metabol.2026.156547_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104645","article-title":"The active GLP-1 analogue liraglutide alleviates H9N2 influenza virus-induced acute lung injury in mice","volume":"150","author":"Bai","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.metabol.2026.156547_bb0600","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/SHK.0000000000002285","article-title":"Liraglutide alleviates acute lung injury and mortality in pneumonia-induced sepsis through regulating surfactant protein expression and secretion","volume":"61","author":"Guo","year":"2024","journal-title":"Shock"},{"key":"10.1016\/j.metabol.2026.156547_bb0605","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.metabol.2026.156547_bb0610","doi-asserted-by":"crossref","first-page":"L368","DOI":"10.1152\/ajplung.00041.2023","article-title":"Liraglutide pretreatment attenuates sepsis-induced acute lung injury","volume":"325","author":"Baer","year":"2023","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.metabol.2026.156547_bb0615","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2359677","article-title":"The human gut microbiome and aging","volume":"16","author":"Bradley","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.metabol.2026.156547_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102950","article-title":"Aging in women - The microbiome perspective","volume":"113","author":"Ferrando","year":"2026","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.metabol.2026.156547_bb0625","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijbiomac.2022.02.056","article-title":"Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4\/NF-\u03baB signaling pathway","volume":"205","author":"Fang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.metabol.2026.156547_bb0630","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13046-020-01782-w","article-title":"Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPAR\u03b1 to activate the NF-\u03baB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance","volume":"40","author":"Kong","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.metabol.2026.156547_bb0635","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3389\/fimmu.2020.01387","article-title":"The NF-\u03baB signaling pathway, the microbiota, and gastrointestinal tumorigenesis: Recent advances","volume":"11","author":"Peng","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.metabol.2026.156547_bb0640","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.semcancer.2022.02.007","article-title":"Chemokines in colon cancer progression","volume":"86","author":"Jia","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.metabol.2026.156547_bb0645","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/imm.13784","article-title":"GLP-1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells","volume":"172","author":"Sun","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.metabol.2026.156547_bb0650","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0655","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/hep.32235","article-title":"A GLP-1\/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome","volume":"75","author":"Kim","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156547_bb0660","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamainternmed.2024.4661","article-title":"GLP-1 receptor agonists and risk for cirrhosis and related complications in patients with metabolic dysfunction-associated steatotic liver disease","volume":"184","author":"Kanwal","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0665","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41575-025-01099-z","article-title":"Liver, ageing and disease","volume":"22","author":"Le Couteur","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.metabol.2026.156547_bb0670","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2337\/dc24-0860","article-title":"Diabetes, prediabetes, and brain aging: The role of healthy lifestyle","volume":"47","author":"Dove","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156547_bb0675","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ecl.2022.10.006","article-title":"Type 1 diabetes and aging","volume":"52","author":"Toschi","year":"2023","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.metabol.2026.156547_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102817","article-title":"Emerging uncertainty on the anti-aging potential of metformin","volume":"111","author":"Keys","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.metabol.2026.156547_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114713","article-title":"Mulberry leaves ameliorate diabetes via regulating metabolic profiling and AGEs\/RAGE and p38 MAPK\/NF-\u03baB pathway","volume":"283","author":"Li","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117146","article-title":"HMGB1 upregulates NF-kB by inhibiting IKB-\u03b1 and associates with diabetic retinopathy","volume":"241","author":"Liang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.metabol.2026.156547_bb0695","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.123.067584","article-title":"Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria","volume":"149","author":"Neuen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2026.156547_bb0700","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1111\/dom.15869","article-title":"Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: a global retrospective cohort study","volume":"26","author":"Huang","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.metabol.2026.156547_bb0705","doi-asserted-by":"crossref","first-page":"218","DOI":"10.29271\/jcpsp.2019.03.218","article-title":"Effects of liraglutide combined with insulin on oxidative stress and serum MCP-1 and NF-kB levels in type 2 diabetes","volume":"29","author":"Liu","year":"2019","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"10.1016\/j.metabol.2026.156547_bb0710","article-title":"GLP-1 alleviates NLRP3 inflammasome-dependent inflammation in perivascular adipose tissue by inhibiting the NF-\u03baB signalling pathway","volume":"49","author":"Chen","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.metabol.2026.156547_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2022.102079","article-title":"Spinal cord-wide structural disruption in type 2 diabetes rescued by exenatide \u201ca glucagon-like peptide-1 analogue\u201d via down-regulating inflammatory, oxidative stress and apoptotic signaling pathways","volume":"121","author":"Mandour","year":"2022","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.metabol.2026.156547_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102245","article-title":"Multiomics insights into the female reproductive aging","volume":"95","author":"Wei","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.metabol.2026.156547_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114603","article-title":"Testicular aging: Mechanism, management and future therapy","volume":"449","author":"Zhou","year":"2025","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.metabol.2026.156547_bb0730","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/humrep\/dead177","article-title":"Human ovarian aging is characterized by oxidative damage and mitochondrial dysfunction","volume":"38","author":"Smits","year":"2023","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.metabol.2026.156547_bb0735","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.7150\/thno.81406","article-title":"The STAT1\/HMGB1\/NF-\u03baB pathway in chronic inflammation and kidney injury after cisplatin exposure","volume":"13","author":"Fu","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.metabol.2026.156547_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113056","article-title":"Glutamine prevents upregulation of NF-kB signaling and caspase 3 activation in ischaemia\/reperfusion-induced testicular damage: An animal model","volume":"150","author":"Afolabi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.metabol.2026.156547_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.967151","article-title":"MiR-93-5p promotes granulosa cell apoptosis and ferroptosis by the NF-kB signaling pathway in polycystic ovary syndrome","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.metabol.2026.156547_bb0750","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-022-01289-w","article-title":"Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-\u03baB-IL6-STAT3 axis","volume":"10","author":"Zhong","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.metabol.2026.156547_bb0755","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1224985","article-title":"Liraglutide ameliorates diabetic-induced testicular dysfunction in male rats: role of GLP-1\/Kiss1\/GnRH and TGF-\u03b2\/smad signaling pathways","volume":"14","author":"Fathy","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0760","article-title":"Exploring the potential impact of GLP-1 receptor agonists in cancer therapy","author":"Aslam","year":"2023","journal-title":"Minerva Endocrinol. (Torino)"},{"key":"10.1016\/j.metabol.2026.156547_bb0765","article-title":"A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS","volume":"20","author":"Bader","year":"2024","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.metabol.2026.156547_bb0770","article-title":"The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials","volume":"38","author":"de Athayde","year":"2024","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.metabol.2026.156547_bb0775","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2147\/DDDT.S484531","article-title":"Semaglutide alleviates ovary inflammation via the AMPK\/SIRT1\/NF-\u03baB signaling pathway in polycystic ovary syndrome mice","volume":"18","author":"Liu","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.metabol.2026.156547_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.111052","article-title":"Effects of GH\/IGF axis on bone and cartilage","volume":"519","author":"Dixit","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.metabol.2026.156547_bb0785","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41574-025-01088-x","article-title":"Bone and muscle crosstalk in ageing and disease","volume":"21","author":"Kirk","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.metabol.2026.156547_bb0790","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.3390\/ijms22073553","article-title":"Skeletal aging and osteoporosis: Mechanisms and therapeutics","volume":"22","author":"Chandra","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.metabol.2026.156547_bb0795","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00198-022-06557-x","article-title":"The potential mechanism of the microbiota-gut-bone axis in osteoporosis: A review","volume":"33","author":"He","year":"2022","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.metabol.2026.156547_bb0800","doi-asserted-by":"crossref","first-page":"12515","DOI":"10.1096\/fj.201802805RR","article-title":"Activation of ROS\/MAPKs\/NF-\u03baB\/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis","volume":"33","author":"An","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.metabol.2026.156547_bb0805","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.joca.2023.11.018","article-title":"Aging and the emerging role of cellular senescence in osteoarthritis","volume":"32","author":"Diekman","year":"2024","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.metabol.2026.156547_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101902","article-title":"Epigenetic modifications of inflammation in intervertebral disc degeneration","volume":"87","author":"Kang","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.metabol.2026.156547_bb0815","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2147\/JIR.S489613","article-title":"The Interplay of Aging and PANoptosis in Osteoarthritis Pathogenesis: Implications for Novel Therapeutic Strategies","volume":"18","author":"Liu","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.metabol.2026.156547_bb0820","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/jc.2015-1176","article-title":"GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women","volume":"100","author":"Iepsen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2026.156547_bb0825","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jbmr.1898","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats","volume":"28","author":"Ma","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.metabol.2026.156547_bb0830","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12020-014-0361-4","article-title":"Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists\u2019 treatment: A meta-analysis of randomized controlled trials","volume":"48","author":"Su","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.metabol.2026.156547_bb0835","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","article-title":"Once-weekly semaglutide in persons with obesity and knee osteoarthritis","volume":"391","author":"Bliddal","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0840","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMe2409972","article-title":"Glucagon-like peptide-1 receptor agonists and osteoarthritis","volume":"391","author":"Felson","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0845","doi-asserted-by":"crossref","first-page":"eadt0548","DOI":"10.1126\/science.adt0548","article-title":"Osteoarthritis treatment via the GLP-1-mediated gut-joint axis targets intestinal FXR signaling","volume":"388","author":"Yang","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.metabol.2026.156547_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107841","article-title":"Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1\/NF-\u03baB pathway","volume":"98","author":"Ren","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0855","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0860","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/ciia.2006.1.3.253","article-title":"Effect of aging on respiratory system physiology and immunology","volume":"1","author":"Sharma","year":"2006","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.metabol.2026.156547_bb0865","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158448","article-title":"Connecting aging biology and inflammation in the omics era","volume":"132","author":"Walker","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.metabol.2026.156547_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101932","article-title":"Structural and physiological changes of the kidney with age and its impact on chronic conditions and COVID-19","volume":"88","author":"Ray","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.metabol.2026.156547_bb0875","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.freeradbiomed.2024.11.046","article-title":"Reactive oxygen species in the pathogenesis of sarcopenia","volume":"227","author":"Xu","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0880","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s43587-021-00044-4","article-title":"Disparities in the pace of biological aging among midlife adults of the same chronological age have implications for future frailty risk and policy","volume":"1","author":"Elliott","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.metabol.2026.156547_bb0885","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14054","article-title":"Aging in the dermis: Fibroblast senescence and its significance","volume":"23","author":"Zhang","year":"2024","journal-title":"Aging Cell"},{"key":"10.1016\/j.metabol.2026.156547_bb0890","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jacc.2021.12.017","article-title":"Inflammation, aging, and cardiovascular disease: JACC review topic of the week","volume":"79","author":"Liberale","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.metabol.2026.156547_bb0895","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbi.2024.02.025","article-title":"Impact of high-fat diet on cognitive behavior and central and systemic inflammation with aging and sex differences in mice","volume":"118","author":"Evans","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.metabol.2026.156547_bb0900","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41577-022-00751-y","article-title":"DNA damage and repair in age-related inflammation","volume":"23","author":"Zhao","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.metabol.2026.156547_bb0905","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: From mechanisms to therapeutic advances","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.metabol.2026.156547_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118660","article-title":"Lycopodium japonicum thunb. inhibits chondrocyte apoptosis, senescence and inflammation in osteoarthritis through STING\/NF-\u03baB signaling pathway","volume":"335","author":"Ma","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113151","article-title":"The ellagitannin metabolite urolithin C attenuated cognitive impairment by inhibiting neuroinflammation via downregulation of MAPK\/NF-kB signaling pathways in aging mice","volume":"142","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.metabol.2026.156547_bb0920","article-title":"Chronic exposure to bioaerosols in PM2.5 from garbage stations accelerates vascular aging via the NF-\u03baB\/NLRP3 pathway","volume":"11","author":"Chen","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.metabol.2026.156547_bb0925","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2025.3599","article-title":"Oral semaglutide in an East Asian population with overweight or obesity, with or without type 2 diabetes: the OASIS 2 randomized clinical trial","author":"Kadowaki","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.metabol.2026.156547_bb0930","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2420771","article-title":"Symbiotic probiotic communities with multiple targets successfully combat obesity in high-fat-diet-fed mice","volume":"16","author":"Guo","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.metabol.2026.156547_bb0935","doi-asserted-by":"crossref","first-page":"468","DOI":"10.14336\/AD.2021.0928","article-title":"Novel insights into the roles and mechanisms of GLP-1 receptor agonists against aging-related diseases","volume":"13","author":"Peng","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.metabol.2026.156547_bb0940","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.cmet.2025.10.014","article-title":"Body-wide multi-omic counteraction of aging with GLP-1R agonism","volume":"37","author":"Huang","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.metabol.2026.156547_bb0945","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.metabol.2026.156547_bb0950","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70147","article-title":"An update on GLP-1 receptor agonists","volume":"17","author":"Bloomgarden","year":"2025","journal-title":"J. Diabetes"}],"updated-by":[{"DOI":"10.1016\/j.metabol.2026.156694","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526000569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526000569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T10:54:41Z","timestamp":1786013681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526000569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":190,"alternative-id":["S0026049526000569"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156547","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging: Mechanisms and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156547"}}